COVID-19 vaccine from Moderna 'provides good clinical protection' against Omicron subvariants

Omicron subvariants BA.4 and BA.5 are becoming the dominant forms of COVID-19 in Australia and abroad. New data from Moderna shows an updated booster tailored to Omicron generates high levels of antibodies against BA.4 and BA.5. Moderna's chief medical officer says, pending approval, the new booster could be supplied to Australia in August